SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-001017
Filing Date
2024-02-13
Accepted
2024-02-13 07:01:49
Documents
64
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20231231x10q.htm   iXBRL 10-Q 1290409
2 EX-31.1 tmb-20231231xex31d1.htm EX-31.1 7131
3 EX-31.2 tmb-20231231xex31d2.htm EX-31.2 7121
4 EX-32.1 tmb-20231231xex32d1.htm EX-32.1 9215
5 GRAPHIC tmb-20231231x10q001.jpg GRAPHIC 17235
6 GRAPHIC tmb-20231231x10q003.jpg GRAPHIC 38174
7 GRAPHIC tmb-20231231x10q004.jpg GRAPHIC 38064
  Complete submission text file 0001558370-24-001017.txt   5321258

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20231231.xsd EX-101.SCH 36699
9 EX-101.CAL tmb-20231231_cal.xml EX-101.CAL 36532
10 EX-101.DEF tmb-20231231_def.xml EX-101.DEF 112408
11 EX-101.LAB tmb-20231231_lab.xml EX-101.LAB 298867
12 EX-101.PRE tmb-20231231_pre.xml EX-101.PRE 220569
66 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231231x10q_htm.xml XML 794688
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37410 | Film No.: 24622558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)